|

Exercise Training After Upper Gastrointestinal Cancer Surgery

RECRUITINGN/ASponsored by Kansai Medical University
Actively Recruiting
PhaseN/A
SponsorKansai Medical University
Started2026-05-15
Est. completion2029-11
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

This randomized controlled trial aims to determine the optimal exercise intensity for improving postoperative recovery in patients with upper gastrointestinal cancer. Participants who have undergone curative surgery will be randomly assigned to high-intensity interval training (HIIT), low-intensity continuous training (LICT), or usual care. The exercise interventions will be performed under supervision three times per week for eight weeks. The primary outcome is peak oxygen uptake (VO₂peak), assessed using cardiopulmonary exercise testing. Secondary outcomes include physical function, body composition, patient-reported outcomes, and biological and mechanistic markers such as inflammatory biomarkers, muscle-related factors, and gut microbiota. This study will also explore potential mechanisms underlying exercise-induced adaptations and their association with clinical outcomes.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Age ≥ 18 years
* Diagnosed with esophageal or gastric cancer
* Received curative surgery
* 6 ± 2 weeks after surgery
* Ability to provide written informed consent

Exclusion Criteria:

* Communication difficulties
* Poor general status
* Undergone combined laryngopharyngectomy
* Unsuitable for evaluation or exercise intervention
* Unsuitable for the study as determined by the primary physician

Conditions4

CancerEsophageal CancerGastric Cancer (Diagnosis)Upper Gastrointestinal Cancer

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.